by Jessica Casebolt | Jun 21, 2024 | Opioid/Substance Use Disorders, Tea Leaves
A recent federal study revealed that only 4.1 percent of traditional Medicare enrollees who survived a nonfatal drug overdose in 2020 received effective medications for opioid use disorder within the following year, such as methadone or buprenorphine. This finding...
by Jessica Casebolt | Jun 21, 2024 | Access & Coverage, Tea Leaves
The Congressional Budget Office (CBO) anticipates a rise in the uninsured rate in the United States over the next decade, with projections indicating an increase from 7.7 percent this year to 8.9 percent by 2034. Currently, 26 million people lack health coverage, up...
by Jessica Casebolt | Jun 21, 2024 | Providers, Tea Leaves
Amazon Pharmacy has extended its RxPass prescription drug subscription program to include Prime members enrolled in Medicare insurance. Launched in January 2023, RxPass offers Prime members unlimited access to 60 generic medications, delivering them directly to...
by Jessica Casebolt | Jun 21, 2024 | Payers, Tea Leaves
The Centers for Medicare and Medicaid Services (CMS) announced the conclusion of its financial relief program for providers impacted by the Change Healthcare cyberattack. Starting July 12, CMS will no longer accept new applications for accelerated or advance payments,...
by Jessica Casebolt | Jun 21, 2024 | Opioid/Substance Use Disorders, Tea Leaves
In the realm of health care, addiction remains highly stigmatized, particularly among pregnant women who use drugs, facing condemnation across various systems. Agencies often remove newborns from drug-positive mothers without providing adequate support, contributing...
Recent Comments